Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to see how many patients develop hair, skin and nail changes due to cancer treatments. The investigators would like to study the clinical factors, genetic markers, and impact on patients' health-related quality of life to learn more about who is at greater risk. We trust that the study will improve our understanding of how cancer patients feel about their skin, hair, and nail conditions. This information will help us determine the burden on breast cancer patients and survivors. It will also help us learn how to prevent these conditions and it may improve the way we treat them and counsel patients.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT02530177
Study type Observational
Source Memorial Sloan Kettering Cancer Center
Contact
Status Active, not recruiting
Phase
Start date August 19, 2015
Completion date August 2026

See also
  Status Clinical Trial Phase
Recruiting NCT05256745 - RAGE Inhibition to Decrease Cardiotoxicity in Women With Early Breast Cancer Phase 1/Phase 2
Completed NCT02650193 - A Study Of The Safety And Effects Of One Or More Doses Of HSP-130 Injected Under The Skin In Women With Breast Cancer That Has Not Spread To Distant Sites In The Body. Phase 2
Recruiting NCT06400849 - Comparison of the Efficacy of Cryotherapy Combined With Compression in Preventing Neuropathy N/A